Chyna Blain will be responsible for generating new client opportunities at the pharmaceutical forecasting company
J+D Forecasting, one of the world’s leading pharmaceutical forecasting companies, has today announced the appointment of Chyna Blain as Global Business Development Manager.
London based Blain will be responsible for developing relationships with a broad range of pharmaceutical and bio tech companies. As part of the new position, Blain will be attending industry events and conferences to qualify new business opportunities and then cultivate these opportunities to establish and build long-lasting client relationships.
The appointment of Blain builds on the firm’s global expansion plans and commitment to bringing leading-edge forecasting software and consultancy to even more industry-leading pharmaceutical corporations.
Speaking of her appointment, Blain said: “I am delighted to announce my move to J+D Forecasting as Global Business Development Manager. I decided I wanted to be part of J+D’s growing team as I wanted to work in a company where I not only believed in the solutions, but also where I believed in the people I worked with. I automatically saw the value in the J+D offerings, and, when combined with meeting some of the team and hearing about exciting future developments, I knew I wanted to be part of it.
“I am now working towards becoming a key player in the development of the business and helping my colleagues to achieve the company’s ambitious growth plans.”
Blain joins J+D from Informa Plc., where she previously held the position of EMEA Business Development Manager.
David James, J+D Forecasting CEO, commented: “Chyna is already proving to be a valuable member of the team, with visible knowledge and passion for the industry and our services. I am confident that in her role as Global Business Development Manager Chyna will help us to drive the business forward both in Global and local markets, and enable us to achieve our business goals.”
J+D Forecasting was founded over 10 years ago from a passion to support pharmaceutical companies with their forecasting needs. Providing bespoke consultancy services, sophisticated software, and interactive pharma forecasting training, J+D has extensive expertise in Oncology, Cardiology, Diabetes, Respiratory and Auto-immune diseases and has so far applied its knowledge and experience to over 30 countries.